LSE Health and the National Institute for Health and Care Excellence (NICE) are to collaborate on a number of research and educational activities aimed at informing health policy and practice across the UK.
The Memorandum of Understanding (MoU), signed on 15 March 2017, highlights a shared commitment to improving the overall health of the population through informing health policy and practice and in the development, advancement and evaluation of research methodologies.
Academics from LSE Health will work closely with NICE focusing on evidence and methodology development in health technology assessment. On the educational front, it is envisaged that both LSE Health and NICE will develop courses for the industry and public sector. LSE Health will also call upon NICE to provide expert advice in support of students working on a related field for their MSc dissertations.
LSE Health and NICE already work closely on several initiatives. For example, NICE is a member of the Innovative Medicines Initiative-funded Big Data for Better Outcomes Consortium led by LSE Health. The MoU will strengthen this collaboration, which will focus initially on research and education linked to key issues in the field of health policy and health technology assessment.
Professor Elias Mossialos, Director of LSE Health, said: “This is an exciting development that consolidates our long standing relationship with NICE and opens up exciting opportunities for future collaboration.”
Carole Longson MBE, Executive Director, Centre for Health Technology Evaluation, NICE, said: “This collaboration will enhance the potential of both organisations to deliver top quality educational events and research projects for the benefit of the UK and international healthcare systems.”
The collaborative activities will be championed by a Steering Committee with the following members:
- Elias Mossialos, Brian-Abel Smith Professor of Health Policy, LSE
- Alistair Mcguire, Chair of Health Economics, LSE
- Huseyin Naci, Assistant Professor of Health Policy, LSE
- Carole Longson, Director, Centre for Health Technology Evaluation, NICE
- Leeza Osipenko, Associate Director, Scientific Advice, NICE